CVS Health (CVS) Tops Q4 EPS by 14c; Trims Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
CVS Health (CVS) cuts full-year profit outlook
February 7, 2024 6:44 AM ESTCVS Health (NYSE: CVS) unveiled financial results for the fourth quarter and reduced its earnings outlook for 2024.
The stock initially fell in premarket trading before bouncing back into the green.
For FQ4 2023, the company reported earnings per share (EPS) of $2.12, topping the consensus... More
